Medscape www.medscape.com

References for:
Managing Psychiatric Medications in the Breast-Feeding Woman

[Medscape General Medicine 1(3), 1999. © 1999 Medscape]

  1. Stowe Z: Mood and anxiety disorders in the childbearing years. New York, American Psychiatric Association, May 5, 1996.
  2. Kendell RE, Chalmers JC, Platz C: Epidemiology of puerperal psychoses. Br J Psychiatry 150:662-673, 1987.
  3. Task Force on Breast-Feeding: American Academy of Pediatrics: The promotion of breast feeding. Pediatrics 69:654-661,1982.
  4. Committee on Nutrition of the American Academy of Pediatrics: The use of whole cow's milk in infancy. Pediatrics 89:1105-1108, 1992.
  5. Nutrition Committee of the Canadian Pediatric Society and the Committee on Nutrition of the American Academy of Pediatrics: Breastfeeding. Pediatrics 62:591-601, 1978.
  6. Hamosh M: Breast-feeding: Unraveling the mysteries of mother's milk. Medscape 1(9), 1996.
  7. Chen Y, Yu SZ, Li WX: Artificial feeding and hospitalization in the first 18 months of life. Pediatrics 81:58-62, 1988.
  8. Wilson JT: Determinants and consequences of drug excretion in breast milk. Drug Metab Rev 14:619-652, 1983.
  9. Riordan JM: The cost of not breastfeeding: A commentary. J Hum Lact 13:93-97, 1997.
  10. Fälth-Magnusson K, Franzén L, Jansson G, et al: Infant feeding history shows distinct differences between Swedish celiac and reference children. Pediatr Allergy Immunol 7:1-5, 1996.
  11. Arita M, Mikawa H, Shirataka M, et al: Epidemiological research on incidence of atopic disease in infants and children in relation to their nutrition in infancy. Arerugi 46:354-369, 1997.
  12. Rogan WJ, Gladen BC: Breast-feeding and cognitive development. Early Hum Dev 31:181-193, 1993.
  13. Misri S, Sivertz K: Tricyclic drugs in pregnancy and lactation: A preliminary report. Int J Psychiatry Med 21:157-171, 1991.
  14. Wisner KL, Wheeler SB: Prevention of recurrent postpartum major depression. Hosp Community Psychiatry 45: 1191-1196, 1994.
  15. Murray L, Seger D: Drug therapy during pregnancy and lactation. Emerg Med Clin North Am 12:129-149, 1994.
  16. Buist A, Norman TR, Dennerstein L: Breastfeeding and the use of psychotropic medication: A review. J Affect Disord 19:197-206, 1990.
  17. Cavell B: Gastric emptying in infants fed human milk or infant formula. Acta Paediatr Scand 70:639-641, 1981.
  18. Glasier A, McNeilly AS: Physiology of lactation. Baillieres Clin Endocrinol Metab 4:379-395, 1990.
  19. Morselli PL, Morselli-Franco R, Bossi L: Clinical pharmacokinetics in newborns and infants. Clin Pharm 5:485-527, 1980.
  20. Nurnberg HG: Breastfeeding and psychotropic agents. Am J Psychiatry 138:120-121, 1981. Letter.
  21. Rivera-Calimlim L: The significance of drugs in breast milk, pharmacologic considerations. Clin Perinatol 14:51-70, 1987.
  22. Hendrick V, Burt VK, Altshuler LL: Psychotropic guidelines for breast-feeding mothers. Am J Psychiatry 153:1236-1237, 1996.
  23. Breyer-Pfaff U, Nill K, Entenmann KN, et al: Secretion of amitriptyline and metabolites into breast milk. Am J Psychiatry 152:812-813, 1995.
  24. Pittard WB, O'Neal W Jr: Amitriptyline excretion in human milk. J Clin Psychopharmacol 6:383-384, 1986.
  25. Brixen-Rasmussen L, Halgrener J, Jorgensen A: Amitriptyline and nortriptyline excretion in human breast milk. Psychopharmacology (Berl) 76:94-95, 1982.
  26. Bader TF, Newman K: Amitriptyline in human breast milk and nursing infant's serum. Am J Psychiatry 137:855-856, 1980.
  27. Wisner KL, Perel JM: Nortriptyline treatment of breast-feeding women. Am J Psychiatry 153:295, 1996.
  28. Altshuler L, Burt VK, McMullen M, et al: Breastfeeding and sertraline: A 24 hour analysis. J Clin Psychiatry 56:243-245, 1995.
  29. Wisner KL, Perel JM: Serum nortriptyline levels in nursing mothers and their infants. Am J Psychiatry 148:1234-1236, 1991.
  30. Wisner KL, Perel JM, Foglia JP: Serum clomipramine and metabolite levels in four nursing mother-infant pairs. J Clin Psychiatry 56:17-20, 1995.
  31. Schimmell MS, Katz EZ, Shaag Y, et al: Toxic neonatal effects following maternal clomipramine therapy. J Toxicol Clin Toxicol 29:479-484, 1991.
  32. Stancer HC, Reed KL: Desipramine and 2-Hydroxydesipramine in human breast milk and the nursing infant's serum. Am J Psychiatry 143:1597-1600, 1986.
  33. Sovner R, Orsulak P: Excretion of imipramine and desipramine in human breast milk. Am J Psychiatry 136:451-452, 1979.
  34. Kemp J, Ilett KF, Booth J, et al: Excretion of doxepin and n-desmethyldoxepin in human milk. Br J Clin Pharmacol 20:497-499, 1985.
  35. Matheson I, Pande H, Altersen AR: Respiratory depression caused by n-desmethyldoxepin in human milk. Lancet 2:1124, 1985.
  36. Briggs GG, Samson JH, Ambrose PJ, et al: Excretion of bupropion in breast milk. Ann Pharmacother 27:431-433, 1993.
  37. Burch KJ, Wells BG: Fluoxetine/norfluoxetine concentrations in human milk. Pediatrics 89:676-677, 1992.
  38. Isenberg KE: Excretion of fluoxetine in human breast milk. J Clin Psychiatry 51:169, 1990.
  39. Taddio A, Ito S, Koren G: Excretion of fluoxetine and its metabolite, norfluoxetine, in human breast milk. J Clin Pharmacol 36:42-47, 1996.
  40. Lester BM, Cucca J, Andreozzi L, et al: Possible association between fluoxetine hydrochloride and colic in an infant. J Am Acad Child Adolesc Psychiatry 32:1253-1255, 1993.
  41. Spigset O, Carleborg L, Norstrom A, et al: Paroxetine level in breast milk. J Clin Psychiatry 57:39, 1996.
  42. Wright S, Dawling S, Ashford JJ: Excretion of fluovoxamine in breast milk. Br J Clin Pharmacol 31:209, 1991.
  43. Stowe ZN, Owens MJ, Landry JC, et al: Sertraline and desmethylsertraline in human breast milk and nursing infants. Am J Psychiatry 154(9):1255-1260, 1997.
  44. Mammen OK, Perel JM, Rudolph G, et al: Sertraline and norsertraline levels in three breastfed infants. J Clin Psychiatry 58(3):100-103, 1997.
  45. Verbeeck RK, Ross SG, McKenna EA: Excretion of trazodone in breast milk. Br J Clin Pharmacol 22:367-370, 1986.
  46. Dusci LJ, Good SM, Hall RW, et al: Excretion of diazepam and its metabolites in human milk during withdrawal from combinaton high dose diazepam and oxazepam. Br J Clin Pharmacol 29:123-126, 1990.
  47. Erkkola R, Kanto J: Diazepam and breast-feeding. Lancet 1:1235-1236, 1972.
  48. Patrick MJ, Tilstone WJ, Reavey P: Diazepam and breastfeeding. Lancet 1:542-543, 1972.
  49. Brandt R: Passage of diazepam and desmethyldiazepam into breast milk. Arzneimittelforschung 26:454-457, 1976.
  50. Wesson DR, Camber S, Harkey M, et al: Diazepam and desmethyldiazepam in breast milk. J Psychoactive Drugs 17:55-56, 1985.
  51. Fisher JB, Edgren BE, Mammel MC, et al: Neonatal apnea associated with maternal clonazepam therapy: A case report. Obstet Gynecol 66(suppl 3):S34-S35, 1985.
  52. Söderman P, Matheson I: Clonazepam in breast milk. Eur J Pediatr 147:212-213, 1988.
  53. Oo CY, Kuhn RJ, Desai N, et al : Pharmacokinetics in lactating women: Prediction of alprazolam transfer into milk. Br J Clin Pharmacol 40:231-236, 1995.
  54. Anderson PO, McGuire GG: Neonatal alprazolam withdrawal--Possible effects of breast feeding. Ann Pharmacother 23:614, 1989.
  55. Summerfield RJ, Nielsen MS: Excretion of lorazepam into breast milk. Br J Anaesth 57:1042-1043, 1985.
  56. Lebedevs TH, Wojnar-Horton RE, Yapp P, et al: Excretion of temazepam in breast milk. Br J Clin Pharmacol 33:204-206, 1992.
  57. Wretlind M: Excretion of oxazepam in breast milk. Eur J Clin Pharmacol 33:209-210, 1987.
  58. Blacker KH, Weinstein BJ, Ellman G: Mother's milk and chlorpromazine. Am J Psychiatry 178:119, 1962.
  59. Wiles DH, Orr MW, Kolakowska T: Chlorpromazine levels in plasma and milk of nursing mothers. Br J Clin Pharmacol 5:272-273, 1978.
  60. Kris E, Carmichael D: Chlorpromazine maintenance therapy during pregnancy and confinement. Psychiatr Q 31:690-695, 1957.
  61. Olesen OV, Barteles U, Poulsen JH: Perphenazine in breast milk and serum. Am J Psychiatry 147:1378-1379, 1990.
  62. Whalley LJ, Blain PG, Prime JK: Haloperidol secreted in breast milk. Br Med J 282:1746-1747, 1981.
  63. Stewart RB, Karas B, Springer PK: Haloperidol excretion in human milk. Am J Psychiatry 137:849-850, 1980.
  64. Matheson I, Evang A, Overo KF, et al: Presence of chlorprothixene and its metabolites in breast milk. Eur J Clin Pharmacol 27:611-613, 1984.
  65. Barnas C, Bergant A, Hummer M, et al: Clozapine concentrations in maternal and fetal plasma, amniotic fluid, and breast milk. Am J Psychiatry 151:945, 1994.
  66. Sykes PA, Quarrie J, Alexander FW: Lithium carbonate and breast-feeding. Br Med J 2:1299, 1976.
  67. Schou M, Amdisen A: Lithium and pregnancy 3: Lithium ingestion by children breast-fed by women on lithium treatment. Br Med J 2:138, 1973.
  68. Ananth J: Lithium during pregnancy and lactation. Lithium 4:231-237, 1993.
  69. Froescher W, Eichelbaum M, Niesen M, et al: Carbamazepine levels in breast milk. Ther Drug Monit 6:266-271, 1984.
  70. Merlob P, Mor N, Litwin A: Transient hepatic dysfunction in an infant of an epileptic mother treated with carbamazepine during pregnancy and breast feeding. Ann Pharmacother 26:1563-1565, 1992.
  71. Frey B, Schubiger G, Musy JP: Transient cholestatic hepatitis in a neonate associated with carbamazepine exposure during pregnancy and breast-feeding. Eur J Pediatr 150:136-138, 1990.
  72. von Unruh GE, Froescher W, Hoffman F, et al: Valproic acid in breast milk: How much is really there? Ther Drug Monit 6:272-276, 1984.
  73. Alexander FW: Sodium valproate and pregnancy. Arch Dis Child 54:240-245, 1979.
  74. Cohen LS, Sichel DA, Robertson LM, et al: Postpartum prophylaxis for women with bipolar disorder. Am J Psychiatry 152:1641-1645, 1995.